|1||NCT00113776||Completed||Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer||
||All||18 Years and older (Adult, Senior)||NCT00113776||20030194||June 13, 2005||January 21, 2011|
|2||NCT03259009||Not yet recruiting||RAS Mutations in ctDNA and Anti-EGFR reINTROduction in mCRC (RASINTRO)||
||73||All||18 Years and older (Adult, Senior)||NCT03259009||RASINTRO||RASINTRO||October 1, 2017||January 1, 2020||June 1, 2020||August 23, 2017||September 11, 2017|
|Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer||
||463||All||18 Years and older (Adult, Senior)||NCT00113763||20020408||January 2004||October 2008||June 2009||June 13, 2005||July 23, 2014||January 3, 2014|
† Study has passed its completion date and status has not been verified in more than two years.